Objectives:

  1. Review the immune response to malignancy, with a focus on what is known of the immune response to lymphoma
  2. Discuss known mechanisms of immune surveillance escape and exploitation with immunotherapy
  3. Review clinical evidence for current use of immunotherapy for NHL and identify future research directions
Session date: 
Monday, July 23, 2018 - 12:00pm to 1:00pm
Speaker Name: 
Michael Leukam MD
Location: 
UCMC
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.